These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma. Poo-Hwu WJ, Ariyan S, Lamb L, Papac R, Zelterman D, Hu GL, Brown J, Fischer D, Bolognia J, Buzaid AC. Cancer; 1999 Dec 01; 86(11):2252-8. PubMed ID: 10590365 [Abstract] [Full Text] [Related]
3. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system. Finley JW, Gibbs JF, Rodriguez LM, Letourneau R, Driscoll D, Kraybill W. Am Surg; 2000 Jun 01; 66(6):527-31; discussion 531-2. PubMed ID: 10888127 [Abstract] [Full Text] [Related]
4. Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma. Turner RM, Bell KJ, Morton RL, Hayen A, Francken AB, Howard K, Armstrong B, Thompson JF, Irwig L. J Clin Oncol; 2011 Dec 10; 29(35):4641-6. PubMed ID: 22067399 [Abstract] [Full Text] [Related]
5. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma. Francken AB, Accortt NA, Shaw HM, Wiener M, Soong SJ, Hoekstra HJ, Thompson JF. Ann Surg Oncol; 2008 May 10; 15(5):1476-84. PubMed ID: 18196345 [Abstract] [Full Text] [Related]
6. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma. Murali R, Hughes MT, Fitzgerald P, Thompson JF, Scolyer RA. Ann Surg; 2009 Apr 10; 249(4):641-7. PubMed ID: 19300224 [Abstract] [Full Text] [Related]
7. Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma. Posther KE, Selim MA, Mosca PJ, Stanley WE, Johnson JL, Tyler DS, Seigler HF. Ann Surg Oncol; 2006 May 10; 13(5):728-39. PubMed ID: 16538415 [Abstract] [Full Text] [Related]
8. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy. Moore Dalal K, Zhou Q, Panageas KS, Brady MS, Jaques DP, Coit DG. Ann Surg Oncol; 2008 Aug 10; 15(8):2206-14. PubMed ID: 18512102 [Abstract] [Full Text] [Related]
9. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry. Eigentler TK, Buettner PG, Leiter U, Garbe C, Central Malignant Melanoma Registry of the German Dermatological Society. J Clin Oncol; 2004 Nov 01; 22(21):4376-83. PubMed ID: 15514379 [Abstract] [Full Text] [Related]
10. Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry. Leiter U, Buettner PG, Eigentler TK, Bröcker EB, Voit C, Gollnick H, Marsch W, Wollina U, Meier F, Garbe C. J Am Acad Dermatol; 2012 Jan 01; 66(1):37-45. PubMed ID: 21700361 [Abstract] [Full Text] [Related]
11. Follow-up of patients with a thin melanoma. Johnson RC, Fenn NJ, Horgan K, Mansel RE. Br J Surg; 1999 May 01; 86(5):619-21. PubMed ID: 10361181 [Abstract] [Full Text] [Related]
12. Analysis of local recurrence and optimizing excision margins for cutaneous melanoma. Ng AK, Jones WO, Shaw JH. Br J Surg; 2001 Jan 01; 88(1):137-42. PubMed ID: 11136327 [Abstract] [Full Text] [Related]
13. Late recurrence (10 years or more) of malignant melanoma in south-east Germany (Saxony). A single-centre analysis of 1881 patients with a follow-up of 10 years or more. Hansel G, Schönlebe J, Haroske G, Wollina U. J Eur Acad Dermatol Venereol; 2010 Jul 01; 24(7):833-6. PubMed ID: 20070457 [Abstract] [Full Text] [Related]
14. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines. Francken AB, Shaw HM, Accortt NA, Soong SJ, Hoekstra HJ, Thompson JF. Ann Surg Oncol; 2007 Jun 01; 14(6):1924-33. PubMed ID: 17357855 [Abstract] [Full Text] [Related]
16. [Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up]. Francken AB, Thompson JF, Bastiaannet E, Hoekstra HJ. Ned Tijdschr Geneeskd; 2008 Mar 08; 152(10):557-62. PubMed ID: 18402322 [Abstract] [Full Text] [Related]
18. Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma. Brewer JD, Christenson LJ, Weenig RH, Weaver AL. Dermatol Surg; 2010 Mar 08; 36(3):368-76. PubMed ID: 20100262 [Abstract] [Full Text] [Related]
19. [Late recurrence of melanoma beyond 10 years]. Avril MF, Nguyen T, Duvillard P, Bognel C, Margulis A. Ann Dermatol Venereol; 1994 Mar 08; 121(6-7):454-8. PubMed ID: 7702277 [Abstract] [Full Text] [Related]